Celerion is a Contract Research Organization (CRO) specializing in Phase I and early-phase clinical trials, including first-in-human studies. They partner with pharmaceutical and biotechnology sponsors to advance new therapies, and emphasize integrity, trust, teamwork, and respect as core values.
Provide physician-level medical oversight for early-phase clinical trials, ensuring participant safety through screening, eligibility review, and real-time clinical decision-making.
Participate in Safety Review Committee meetings and dose-escalation decisions for first-in-human and ascending dose studies.
Review study protocols, informed consent forms, and safety monitoring plans, and serve as medical liaison during audits and inspections.